JENA MANN: Open Payments
NPI 1366857757 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,237 in 50 payments from 10 companies in 2025. Trend: 2023 $11,144 · 2024 $11,282 · 2025 $14,237
Speaker / faculty: $7,240Travel & lodging: $5,472Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $13,356 |
| Ipsen Biopharmaceuticals, Inc | 5 | $213 |
| Amgen Inc. | 5 | $150 |
| Enterra Medical, Inc. | 1 | $149 |
| Phathom Pharmaceuticals, Inc. | 6 | $135 |
| ABBVIE INC. | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| GENZYME CORPORATION | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Organon LLC | 1 | $14 |
Products named: Epclusa, IQIRVO, UPLIZNA, VOQUEZNA, ENTYVIO, CREON, LINZESS, DUPIXENT.
Industry payments across TX — which companies pay providers there.
